C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer's Disease Model Associated with Vascular Dysfunction
Alzheimer's disease (AD) is a neurological disorder characterized by neuronal cell death, tau pathology, and excessive inflammatory responses. Several vascular risk factors contribute to damage of the blood-brain barrier (BBB), secondary leak-out of blood vessels, and infiltration of inflammato...
Saved in:
Main Authors: | Xiaoxiao Fu (Author), Jing Wang (Author), Huaying Cai (Author), Hong Jiang (Author), Shu Han (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model
by: Haohao Chen, et al.
Published: (2019) -
Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment
by: Fu XX, et al.
Published: (2022) -
Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model
by: Yuanyuan Zhang, et al.
Published: (2018) -
Overexpression of NOX2 Exacerbates AngII-Mediated Cardiac Dysfunction and Metabolic Remodelling
by: Synne S. Hansen, et al.
Published: (2022) -
Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model
by: Marong eFang, et al.
Published: (2013)